Business Context and Reporting Period
Company: American Public Education, Inc. (APEI)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2026
Business Overview: APEI provides online and campus-based postsecondary education through two reportable segments: Military+ (serving military, veterans, and public service communities) and Health+ (nursing and health sciences). Effective March 2, 2026, the company completed the legal merger of its three institutions (APUS, Rasmussen University, and Hondros College of Nursing) into a single surviving entity, American Public University System, Inc., pending final regulatory approval for the full institutional combination.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Revenue | $174.7 million | $164.6 million |
| Net Income | $17.7 million | $8.9 million |
| Diluted EPS | $0.94 | $0.41 |
| Operating Margin | 12.4% | 7.4% |
| Cash from Operations | $63.3 million | $37.0 million |
| Cash & Equivalents (End of Period) | $221.0 million | $187.5 million |
| Total Debt (Principal) | $90.0 million | $96.4 million |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated revenue increased 6.2% year-over-year, driven by a 6.5% increase in the Military+ segment (due to higher net course registrations) and an 11.0% increase in the Health+ segment (due to enrollment growth and tuition increases). This growth was partially offset by the absence of revenue from Graduate School USA (GSUSA), which was sold in July 2025.
- Profitability: Net income doubled to $17.7 million, primarily due to revenue growth and a reduction in operating costs as a percentage of revenue. Operating margin improved significantly from 7.4% to 12.4%.
- Debt Refinancing: On March 9, 2026, the company entered a new $90 million term loan and $40 million revolving credit facility, replacing the prior credit agreement. This resulted in a $1.7 million loss on extinguishment of debt.
- Segment Performance: The Military+ segment operating margin expanded to 34.3% (from 28.7%), while the Health+ segment improved from a loss of 1.1% to a profit margin of 0.6%.
Outlook, Risks, and Management Commentary
- Combination Progress: The company expects to complete the full institutional combination of APUS, RU, and HCN in the third quarter of 2026, subject to U.S. Department of Education (ED) and state approvals. Professional fees for the combination are expected to range between $1.0 million and $3.0 million for the remainder of 2026.
- Regulatory Risks: The company faces risks related to the 90/10 Rule compliance, particularly regarding delayed billing of Department of Defense (DoD) Tuition Assistance (TA) funds. Between January and April 2026, the company received 646 Borrower Defense to Repayment (BDTR) claims seeking approximately $11.0 million in loan discharges; the company disputes these claims.
- Liquidity: Cash and cash equivalents increased by $44.5 million to $221.0 million, largely due to the collection of $33.3 million in previously delayed TA receivables. The company maintains a minimum unrestricted cash covenant of $40.0 million under its new credit agreement.
- Capital Allocation: The Board approved a new $50 million common stock repurchase program on March 10, 2026. During Q1 2026, the company repurchased 17,840 shares for $1.0 million.
Investor Verification Checklist
- Regulatory Approval Status: Verify the timeline and likelihood of ED approval for the full institutional combination of APUS, RU, and HCN.
- BDTR Claims Exposure: Monitor the resolution of the 646 pending Borrower Defense to Repayment claims and potential financial impact if granted.
- 90/10 Rule Compliance: Assess the impact of DoD TA billing delays on the company's ability to maintain the required 90/10 ratio for Title IV eligibility.
- Debt Covenant Compliance: Confirm continued compliance with the new 2026 Credit Agreement covenants, specifically the Consolidated Total Net Leverage Ratio (currently negative 0.10) and minimum cash balance requirements.
- Health+ Margin Sustainability: Evaluate whether the Health+ segment can sustain profitability given the high reliance on Title IV funding (76-84% of revenue) and rising instructional costs.